Dr. Jason Gallagher Discusses FDA’s Decision to Revoke Emergency Use Authorization for Last Remaining Monoclonal Antibody Treatment for COVID-19

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, Clinical Professor and Director of the Postgraduate Year Two Infectious Diseases Residency at the Temple University School of Pharmacy and Clinical Pharmacist Specialist in Infectious Diseases at Temple University Hospital, spoke with Verywell Health about the U.S. Food and Drug Administration (FDA)’s decision to revoke emergency use authorization for the last remaining monoclonal antibody treatment for COVID-19.